Iovance Biotherapeutics Inc. buy Truist Financial Co.
Start price
03.03.25
/
50%
€3.84
Target price
03.03.26
€14.29
Performance (%)
-44.21%
Price
22:26
€2.14
Summary
This prediction is currently active. Massive losses of -44.21% have been the result for the BUY prediction by Truist_Financial_Co_. This prediction currently runs until 03.03.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | -1.471% | -1.471% |
| iShares Core DAX® | 0.060% | 1.215% |
| iShares Nasdaq 100 | -3.065% | -0.519% |
| iShares Nikkei 225® | -2.094% | -3.066% |
| iShares S&P 500 | -1.657% | -0.069% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Truist Financial Co. from $25.00 to $15.00. They now have a "buy" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€6.20
27.12.23
27.12.23
€15.35
27.12.24
27.12.24
12.30%
28.12.24
28.12.24
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€5.09
15.09.23
15.09.23
€15.92
15.09.24
15.09.24
76.82%
16.09.24
16.09.24